Mizuho Initiates Coverage on Aflac (AFL) with Cautious Outlook Citing Stagnant Sales Growth

Group 1 - Aflac Incorporated (NYSE:AFL) is currently viewed as a profitable value stock, but Mizuho has initiated coverage with an Underperform rating and a price target of $104, citing concerns over stagnant sales growth in key markets [1][3] - The company operates primarily in two segments: Aflac Japan and Aflac US, providing supplemental health and life insurance products [4] - Aflac has partnered with Ameriflex to enhance consumer-directed health care solutions, specifically targeting the public sector market, aiming to combine Aflac's insurance products with Ameriflex's administrative expertise [2][3]